NCT05316155 2026-03-13
Study of Erdafitinib Intravesical Delivery System for Localized Bladder Cancer
Janssen Research & Development, LLC
Phase 1/2 Recruiting
Clinical Trials
3 trialsNCT03732703 2025-02-14
MyDRUG
Multiple Myeloma Research Consortium
Phase 1/2 Completed
NCT02421185 2025-02-03
Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of JNJ-42756493 (Erdafitinib) in Participants With Advanced Hepatocellular Carcinoma
Janssen Research & Development, LLC
Phase 1/2 Completed